Before You Begin
Question #46428
The Question
Read the following statements correlating Chemical Evolution with Biotechnology:
I. The Miller-Urey experiment proved that under primitive reducing conditions ( at ), functional and folded polypeptides could be synthesized abiotically. II. The universal nature of the genetic code allows a human structural gene to be translated in a bacterial cell, but it does not guarantee a biologically active complex protein. III. Transgenic animals are utilized to produce complex human therapeutic proteins (e.g., -1-antitrypsin) because they possess the necessary eukaryotic post-translational modification machinery. IV. While modern transgenic expression requires specific regulatory sequences, the abiotic synthesis of amino acids in the Miller-Urey apparatus was directed by primitive ribozymes.
Which of the following options correctly identifies the INCORRECT statements?
Options
- A.
I and IV only
- B.
II and III only
- C.
I, II, and IV only
- D.
III and IV only
Check Your Answer
Correct Answer
Step-by-Step Solution
Explanation
How the Examiner Thinks
Comparative_Analysis
Sharpen your ability to evaluate multiple scenarios and distinguish between competing potential answers.
Concepts Behind This Question
Polypeptides|Genetic_Code|Transgenic_Models
Why This Question Is Tricky
Common Mistakes
Conceptual Pivot: Distinguishing between the mere availability of building blocks (amino acids via abiotic synthesis) and the highly regulated, machinery-dependent process of functional protein expression (transgenic eukaryotes).
The trap lies in over-extrapolating Miller-Urey's results from 'amino acids' to 'polypeptides', and confusing the 'Universal Genetic Code' as a guarantee for functional protein expression while ignoring the necessity of post-translational modifications.
Quick Facts About This Question
Question Information
| Subject | Biology |
| Chapter | Evolution - Class 12 |
| Concept | Miller-Urey Conditions |
| Difficulty | 8 |
| Cognitive Load | 5 |
| Target Solve Time | 120 sec |
| Access | Free |